Status:
COMPLETED
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-120 years
Brief Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE:...
Detailed Description
OBJECTIVES: Primary * To identify gene sets for risk of recurrence using molecular profiling in samples from women with lymph node-positive or high-risk lymph node-negative breast cancer on clinical...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed breast cancer tumor samples collected on clinical trial ECOG-E2197
- Histologically lymph node-positive (N1-3) OR high-risk lymph node-negative disease
- Hormone receptor-positive or negative disease (status known)
- HER2 status known
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
June 17 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 2 2013
Estimated Enrollment :
2541 Patients enrolled
Trial Details
Trial ID
NCT00897845
Start Date
June 17 2008
End Date
December 2 2013
Last Update
May 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.